,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1854863,11238147,Comparative Toxicogenomics Database (CTD),"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide",C492448,ICG 001,https://ctdbase.org/detail.go?type=chem&acc=C492448,387882,C12ORF75,https://ctdbase.org/detail.go?type=gene&acc=387882,,,387882,C12orf75,9606,Homo sapiens (human),ICG 001 results in increased expression of C12ORF75 mRNA,,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
1,1854864,11238147,Comparative Toxicogenomics Database (CTD),"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide",C492448,ICG 001,https://ctdbase.org/detail.go?type=chem&acc=C492448,84419,C15ORF48,https://ctdbase.org/detail.go?type=gene&acc=84419,,,84419,C15orf48,9606,Homo sapiens (human),ICG 001 results in increased expression of C15ORF48 mRNA,,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
2,1854865,11238147,Comparative Toxicogenomics Database (CTD),"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide",C492448,ICG 001,https://ctdbase.org/detail.go?type=chem&acc=C492448,284018,C17ORF58,https://ctdbase.org/detail.go?type=gene&acc=284018,,,284018,C17orf58,9606,Homo sapiens (human),ICG 001 results in increased expression of C17ORF58 mRNA,,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
3,1854866,11238147,Comparative Toxicogenomics Database (CTD),"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide",C492448,ICG 001,https://ctdbase.org/detail.go?type=chem&acc=C492448,83608,C18ORF21,https://ctdbase.org/detail.go?type=gene&acc=83608,,,83608,C18orf21,9606,Homo sapiens (human),ICG 001 results in decreased expression of C18ORF21 mRNA,,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
4,1854867,11238147,Comparative Toxicogenomics Database (CTD),"(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide",C492448,ICG 001,https://ctdbase.org/detail.go?type=chem&acc=C492448,84798,C19ORF48P,https://ctdbase.org/detail.go?type=gene&acc=84798,,,84798,C19orf48P,9606,Homo sapiens (human),ICG 001 results in increased expression of C19ORF48P mRNA,,,PMID:26191083,https://www.ncbi.nlm.nih.gov/pubmed/26191083,26191083,,
